FDA Risk Evaluation and Mitigation Strategy Logic Model: A Framework to Link Program Design With Assessment; Draft Guidance for Industry (Catapult's regulatory round-up - May 2024)
Fiche du document
4 novembre 2024
- doi: 10.58079/12m78
info:eu-repo/semantics/openAccess
Sujets proches
Medications Medicaments Prescription drugs Medicines (Drugs) Pharmaceuticals Medicine (Drugs)Citer ce document
« FDA Risk Evaluation and Mitigation Strategy Logic Model: A Framework to Link Program Design With Assessment; Draft Guidance for Industry (Catapult's regulatory round-up - May 2024) », ELSIBI, ID : 10.58079/12m78
Métriques
Partage / Export
Résumé
A Risk Evaluation and Mitigation Strategy (REMS) is a drug safety program that the FDA can require for certain medications with serious safety concerns to help ensure the benefits of the medication outweigh its risks. REMS are designed to reinforce medication use behaviors and actions that support the safe use of that medication. While all medications have labeling that informs health care stakeholders about medication risks, only a few medications require a REMS. FDA can require a REMS befo...
